WebDisclosure WebDisclosure
Basculer en Français
10381 Companies
216557 Keywords
146254 Articles
114657 Press releases
Headlines Articles Press releases AL-S Pharma AG Remove
  1. Home
  2. Companies
  3. AL-S Pharma AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/19/2026 at 07:35, 1 month 23 days ago

    AL-S Pharma's AP-101 Shows Promise in ALS Treatment

    Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
  • BRIEF

    published on 03/19/2026 at 07:35, 1 month 23 days ago

    Le traitement AP-101 d'AL-S Pharma se révèle prometteur dans le traitement de la SLA.

    Essai Clinique Traitement De La SLA Données De La Phase 2 AP-101 Ciblage SOD1
  • PRESS RELEASE

    published on 03/19/2026 at 07:30, 1 month 23 days ago

    Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

    AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression
    ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1
    Logo of AL-S Pharma AG
Accesswire
  • Published on 05/12/2026 at 00:00, 1 hour 4 minutes ago

    PPX Mining Provides Update on Start-up of the Process Plant

  • Published on 05/12/2026 at 00:00, 1 hour 4 minutes ago

    Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event

  • Published on 05/11/2026 at 23:00, 2 hours 4 minutes ago

    Revolve to Present at the 16th Annual LD Micro Invitational on May 18, 2026

  • Published on 05/11/2026 at 19:55, 5 hours 9 minutes ago

    Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement

  • Published on 05/11/2026 at 19:30, 5 hours 34 minutes ago

    Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia

View all ACCESSWIRE
EQS Group
  • Published on 05/12/2026 at 00:19, 45 minutes ago

    EQS-Adhoc: ABO Energy GmbH & Co. KGaA adjusts its forecast for 2026 and complies with the obligation to report losses pursuant to Section 92 of Stock Corporation Act (AktG) – Draft restructuring report submitted

  • Published on 05/11/2026 at 22:05, 2 hours 59 minutes ago

    Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026

  • Published on 05/11/2026 at 22:05, 2 hours 59 minutes ago

    Abivax Announces Results of its May 11, 2026 Annual General Meeting

  • Published on 05/11/2026 at 21:16, 3 hours 48 minutes ago

    Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy

  • Published on 05/11/2026 at 20:42, 4 hours 22 minutes ago

    Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update

View all EQS
Les Echos
  • Published on 05/11/2026 at 19:02, 6 hours 2 minutes ago

    260511 BENETEAU Transactions sur actions propres

  • Published on 05/11/2026 at 18:18, 6 hours 46 minutes ago

    Reporting on share buyback transactions carried out between May 4 and May 5, 2026

  • Published on 05/11/2026 at 18:18, 6 hours 46 minutes ago

    Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026

  • Published on 05/11/2026 at 18:14, 6 hours 49 minutes ago

    Nombre total d'actions et droits de vote - avril 2026

  • Published on 05/11/2026 at 18:14, 6 hours 49 minutes ago

    Number of shares and voting rights - April 2026 (In French only)

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy